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The injection of parental strain lymphoid cells into F1 hybrid animals is known to 
lead to manifestations of graft-versus-host (GVH) 1  reactions. It is generally agreed that 
the initiation of this process is set in motion by parental strain cells recognizing trans- 
plantation antigens the F1 host has inherited from the other parent (1). This recogni- 
tion process is assumed to be accomplished by recognition structures (RS) presumably 
located on the surface of parental strain lymphoid cells. If such a parent-to-F1 GVH 
reaction is considered from a  genetical point of view, it seems reasonable to assume 
that an F1 animal fails to detect on injected parental strain lymphoid cells any foreign- 
ness, with the notable exception of particular recognition structures. 
It was demonstrated earlier (2-4) that these structures were antigenic. The injection 
of moderate numbers of parental strain immunocompetent cells into F1 hosts led to the 
production of anti-recognition structure (anti-RS) antisera. The activity of these sera 
could be demonstrated by their ability to block the corresponding recognition struc- 
tures  on parental strain cells and  thus prevent antigenic recognition. Anti-RS sera 
have, furthermore, been shown to be of exquisite specificity. Since for genetic reasons 
an F1 host can be expected to react only against RS which it does not possess, its serum 
will contain only antibody to the newly introduced parental RS. It could be shown that 
treatment of a  suspension of parental strain lymphoid cells with such an antiserum 
blocked the  RS  in  question but  left RS  for  other  transplantation antigens  free  to 
recognize corresponding antigens (3, 4). 
While these anti-RS sera have all been provoked by injections of low num- 
bers of parental strain lymphoid cells into  adult F~ hybrid hosts,  the present 
communication  intends  to  show  that  similar antibodies can  be  elicited by  a 
seemingly  remote  immunization  procedure.  Instead  of  considering  only  im- 
munocompetent  cells  as  bearers  of  recognition  structures  for  foreign  trans- 
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plantation antigens, it does  not seem altogether  impossible to view antigenic 
determinants  on  the  combining region  of  alloantibodies  as  possibly  similar 
structures.  That  this  may be so  is forcefully indicated by the fact  that  allo- 
antibodies combine with antigens in immunologically specific ways giving rise 
to a  variety of serological manifestations (5, 6). In following the consideration 
that  alloantibodies might represent recognition structures  for  the immunizing 
antigen, F1 animals were immunized with an alloantiserum possessing an anti- 
gen-binding specificity directed against one of the antigens of the host. It was 
hoped that in this way an anti-alloantiserum could be provoked which would 
in effect be an anti-RS serum. The results of this paper show that such a serum 
behaved precisely like an anti-RS serum raised in similar F1 hosts  by the in- 
jection of parental strain lymphoid cells. 
Materials and Methods 
Animals and Provocation of Antisera.--Adult male and female rats of inbred strains DA, 
Lewis, and BN, as well as F1 hybrids between these strains, were employed. 
An alloantiserum DA anti-Lewis (serum 620) was prepared by grafting six female DA rats 
once with full-thickness skin taken from female Lewis rats according to a standard procedure 
(7). 3 wk postoperatively animals were exsanguinated and the serum pool was heat inactivated 
(30 min at 56°C) and sterilized by Millipore filtration (Millipore Corp., Bedford, Mass.). 
An anti-RS serum of specificity  (Lewis  X  DA)F1 anti-DA RS(Lewis)  (serum  619)  was 
provoked by a  single injection of 106 female DA lymph node cells  (suspended in 0.5 ml of 
Hanks' balanced salt solution [BSS]) by the intravenous route into each of four (Lewis  X 
DA)F1 female rats. Animals were  bled 2 wk later, individual sera pooled,  heat inactivated, 
and sterilized by filtration. A control serum (serum 746) was obtained under identical condi- 
tions by injecting l0 s spleen cells from (Lewis X DA)F1 male donors into five (Lewis  X DA)Ft 
male hosts. 
An anti-alloantiserum (serum  663) of specificity  (Lewis  X  DA)F1 anti-(DA anti-Lewis) 
was elicited in five (Lewis  X  DA)F1 male rats by injecting equal volumes of DA anti-Lewis 
serum 620 and Freund's complete adjuvant (Difco Laboratories, Inc., Detroit, Mich.). Each 
host received  in its belly skin 10 doses of 0.1 ml of this mixture. 2 wk later this procedure 
was repeated and after another 2 wk,  the animals were  exsanguinated, individual sera were 
pooled, heat inactivated, and sterilized. 
A control serum (serum 675) was prepared in five (Lewis X  DA)F1 female rats in exactly 
the same way, except  that  heat-inactivated and filtered serum from normal DA rats was 
injected. 
Product of Antigenic Recognition (PAR)  Assay.--This  test  was  employed  to  estimate 
quantitatively recognition of transplantation antigens present on F 1 hybrid cells by immuno- 
competent cells of parental origin. Procedures of co-cultivating histoincompatible lymphoid 
cells to obtain a product of antigenic recognition and of measuring this product have been 
described  in full (8). Briefly,  suspensions of dissociated  spleen cells were prepared according 
to a standard procedure (7) using Hanks' BSS  (General Biochemicals,  Chagrin Falls, Ohio) 
to which penicillin (100 IU/ml) and streptomycin (50 #g/ml) had been added. Suspensions of 
viable cells were adjusted to contain 20 X  106 cells/ml. To 4 ml of Hanks' BSS  (containing 
penicillin and streptomycin) in Falcon tissue culture dishes  (Falcon Plastics, Los Angeles, 
Calif.)  (60 X  15 ram) were added 0.5 ml of 20 X  106/ml from each of the histoincompatible 
cell suspensions (mixed cultures) or 1 ml of 20 X  106/ml of histocompatible cell suspensions 
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of 95% air to 5% CO2, culture supernatants were harvested, centrifuged, and concentrated by 
lyophilization and  reconstitution with 0.06  M phosphate  buffer,  pH 7.9,  in one-fifth of the 
original volume. After 1 hr at 4°C supernatants  from mixed and unmixed cultures formed 
precipitates spontaneously. These were washed once in the same buffer and were resuspended 
in buffer at  one-tenth of the original volume (0.5 ml for 5 ml of culture fluid or multiples 
thereof).  Well-mixed samples were injected into skin sites marked  on the back  of normal 
Syrian hamsters of agouti type (Tierzuchtinstitut, University of Zurich). PAR, but not control 
culture  fluids,  called  forth  accumulations  of  considerable  numbers  of polymorphonuclear 
(PMN) ceils in ensuing skin lesions. To estimate quantitatively infiltrated cells, hamster hosts 
were killed 24 hr after intracutaneous injections and three of four replicate skin reactions from 
a given sample were excised, cut into small fragments, and were gently trypsinized. PMN cells 
released  were  counted  conventionally and  counts  from  supernatants  of  experimental  cell 
mixtures were corrected for those determined in controls (8). 
Determinations of Activities of Antisera in the PAR Assay.--In  mixed spleen cell cultures 
two populations of cells with distinct properties are employed. Parental strain cells are the 
active partner endowed with the ability to recognize foreign antigens (8, 9). Transplantation 
antigens were offered to these aggressor ceils in the form of appropriate F 1 hybrid spleen cells, 
called target cells. 
Depending on whether a given antiserum addressed its activity to the recognizing proper- 
ties of aggressors  or to the transplantation  antigens of targets,  the PAR assay was set up 
accordingly. Either aggressors  or targets were suspended in concentrations of 20 X  106 cells/ml 
in various dilutions of a serum (using Hanks' BSS as diluent), incubated for 30 rain at 37~C 
in a humid atmosphere of 95% air and 5% CO2, and washed three times in Hanks' BSS by 
centrifugation for 8 rain at 130 g. After counting and readjustment to 20 X  106/ml, cells were 
employed in mixed or unmixed cultures. The other, untreated partner of cell mixtures was 
processed identically but in plain Hanks' BSS. 
While titers of the various antisera were determined in the correct setup, i.e. treatment of 
Fx target cells with alloantisera or treatment of aggressor ceils with antisera directed against 
recognition structures, it was important to show the activities of these antisera in the reversed 
setup. Thus, alloantisera were also used to treat aggressor cells and anti-RS sera were employed 
in the treatment of target cells. 
~S~TS 
Activity and Specificity of Alloantiserum DA Anti-Lewis.--A serum obtained 
after rejection of Lewis skin grafts by DA hosts was expected to be capable of 
blocking Lewis transplantation  antigens on (Lewis X  DA)F1 target spleen cells. 
The  results  in  Table  I  demonstrate  that  serum  620  inhibited  recognition  of 
this  antigen  up  to  a  dilution  of  1:512.  The same  serum  had  no  effect on DA 
aggressor cells, since it failed to block recognition of Lewis alloantigens by DA 
aggressor spleen cells even at high concentrations  (1:32). 
Activity and Specificity of a  (Lewis X  DA)F1 Serum Obtained after Injection 
of DA Node Cetls.--As outlined previously (2-4),  the injection of DA parental 
strain  lymphoid  cells into  (Lewis  X  DA)F1 hosts will lead to the formation of 
an antiserum  directed against structures  on DA cells by means of which Lewis 
transplantation  antigens  are  recognized;  we  call  these  structures  RS(Lewis). 
Employment  of  this  serum  (serum  619)  for  the  treatment  of  DA  aggressor 
cells blocked  recognition  of Lewis  antigens  in  a  dilution  of  1:2048,  as  shown 1086  ANTI-ALLOANTISERUM AND  RECEPTORS 
in  the  upper  part  of  Table  II.  The  F1  serum,  therefore,  possessed anti-DA 
RS(Lewis)  activity.  However,  since immunocompetent  and  potentially anti- 
body-forming cells  were  injected into  F~  hybrids,  the  serum  also  contained 
alloantibodies formed by  the inoculated cells.  For  genetic reasons DA  strain 
TABLE  I 
Titer and Specificity of AlloanHserum DA Anti-Lewis 620 Provoked by Rejection of Lewis Skin 
Grafts  by DA Rats 
Mixed spleen cell cultures* 
PAR~: (±sE) 
Aggressors  Targets 
DA untreated  (Lewis  X  IDA) F1 untreated  5.79  ±  0.41 
DA untreated  (Lewis  X  IDA) F1 +  620 1:32  0.55  ±  0.25 
......  X  ....  +  620  1:64  0  ±  0 
......  X  ....  +  620  1:128  0.50  ±  0.20 
......  X  ....  +  620  1:256  0  ±  0 
......  X  ....  +  620  1:512  0  ±  0 
......  X  "  "  +  620  1:1024  6.00  ±  0.87 
"  "  "  X  ....  +  620  1:2048  6.17  ±  0.21 
IDA +  620  1:32  (Lewis  X  IDA) F1 untreated  6.37  4-  0.16 
* Cultivation was for 7 hr at 37°C. 
X  106 PMN cells/skin reaction. Average of six skin reactions. 
TABLE  II 
Titer and Specificity of Serum 619 Provoked by Injection of DA Lymph Node Cells into (Lewis X 
DA) F1 Hosts 
Acti~  ity 
Anti-DA RS 
(Lewis) 
DA anti-Lewis 
Mixed spleen cell cultures* 
Aggressors 
DA untreated 
DA+619  1:256 
"  3619  1:512 
"  3619  1:1024 
"  3619  1:2048 
"  3619  1:4096 
DA untreated 
Targets 
(Lewis X  DA)F1 untreated 
(Lewis X  DA)F1 untreated 
(Lewis X  DA)F1 +  619  1:16 
"  X  ....  +  619  1:32 
"  X  ....  +  619  1:64 
"  X  "  "  +619  1:128 
"  X  "  "  +  619  1:256 
PAR:~ (±sE) 
8.53  ±  0.60 
0  ±0 
0.31  4-  0.18 
0  ±0 
0  ±0 
9.78  ±  0.12 
6.75  ±  1.04 
0  ±0 
0  ±0 
0.35  ±  0.18 
6.75  ±  0.53 
* Cultivation was for 7 hr at 37°C. 
:~ X  106 PMN cells/skin reaction. Average of 6-18 skin reactions. /:IANSRUEDY  RAMSEIER  AND  JEAN  LINDENMANN  1087 
donor cells are accepted by (Lewis X  DA)F1 hosts which also provide the anti- 
genic  stimulus  (Lewis transplantation  antigens);  in  response to  these,  donor 
cells produced DA  anti-Lewis  alloantibodies.  As  shown  in  the  lower  part  of 
Table II, these prevented recognition of Lewis alloantigens by DA aggressor 
cells to a  comparatively low titer  of 1:128.  Thus, while the  anti-RS  activity 
of this serum is because of a host-anti-inoculum reaction, that of alloantibody 
is the result of an inoculum-anti-host reaction. 
If this is correct, a serum obtained by injecting lymphoid cells from (Lewis X 
DA)Fi  rats  into  (Lewis X  DA)Fi  hosts  should display neither  anti-RS  nor 
alloantibody activity. The results in Table III show  that,  even when  tested 
in high concentration (1:32), such a serum (serum 746) failed to prevent recog- 
nition of Lewis antigens by treated DA aggressors. The same serum also lacked 
activity against Lewis  alloantigens  since  recognition  was normal  after treat- 
ment of target cells. 
TABLE III 
Lack of AntI-RS and of Alloantibody Activity of Serum 746 Provoked by Injection of (Lewis X 
DA)Fi Spleen Cells into  (Lewis X  DA)F1 Hosts 
Mixed spleen cell cultures* 
Activity  PAR~ (±SE) 
Aggressors  Targets 
DA untreated  (Lewis X DA)Ft  9.06  4-  0.28 
untreated 
? Anti-DA  DA +  746  1:32  (Lewis X DA)Fi  8.87  4-  0.37 
RS (Lewis)  untreated 
? DA anti-Lewis  DA untreated  (Lewis X DA)Ft  10.00 4-  0.33 
+  746  1:32 
* Cultivation was for 7 hr at 37°C. 
:~ X 106 PMN cells/skin reaction. Average of six skin reactions. 
Activity  and  Specificity  of  an  Anti-(DA  Anti-Lewis)  Antiserum.--A  serum 
obtained by injecting alloantiserum DA anti-Lewis (serum 620)  into (Lewis X 
DA)Fi hosts was tested for its anti-RS and alloantibody activities, as well as 
for the specificity of its anti-RS  activity. The results obtained with this anti- 
antiserum (serum 663)  are summarized in Table IV. Treatment of DA aggres- 
sor  cells with  serum 663  completely blocked their  ability to recognize Lewis 
alloantigens on (Lewis X  DA)Fi target cells up to a  surprisingly high  titer of 
1:8000.  In contrast to this  clear-cut inhibition,  treatment  of Lewis aggressor 
cells with this serum failed to block recognition of DA alloantigens offered by 
the  same target cells.  Specificity of serum 663  was revealed by the  observa- 
tion that this serum blocked on DA aggressor cells recognition structures for 
Lewis alloantigens only, but not those for transplantation  antigens of a  third- 
party rat  strain.  Thus,  when  treated  DA  cells were confronted with (DA X 
BN)Fi  target  cells,  BN  alloantigens  were  recognized  normally.  Similarly, 1088  ANTI-ALLOANTISERIY/vI  AND  RECEPTORS 
TABLE  IV 
Titer and Specificity  of Anti-Alloantiserum  663 Provoked  by Injection  of Alloantiserum 
DA Anti-Lewis into  (Lewis  X  DA)F~ Hosts 
Mixed spleen cell cultures* 
Activity  PAR+  + (~sE) 
Aggressors  Targets 
DA untreated  (Lewis X  DA)FI untreated  8.84  q-  0.36 
Anti-RS  (Lewis)  DA  +  663  1:32  1:8192  (Lewis  X  DA)F1  untreated  0  ±  0 
"  q-  663  1:16384  "  X  "  "  "  11.58 -4-  0.91 
Lewis untreated  (Lewis  X  DA)FI  untreated  8.12  -4-  0.34 
"  +  663  1:32  "  X  "  "  "  8.87  -4-  0.10 
"  +  663  1:64  "  X  "  "  "  7.20 ±  0.16 
DA untreated  (DA  X  BN)F1 untreated  8.77  -4-  0.27 
"  +  663  1;32  "  X  "  "  "  7.28 -4-  0.18 
~  +  663  1:64  ~  X  "  "  "  7.62 ~___ 0.45 
BN untreated  (DA  X  BN)F1 untreated  7.73  ±  0.46 
"  +  663  l:32  "  X  "  "  "  8.31  ±  0,64 
"  +  663  1:64  "  X  "  "  "  9.38 -4-  0.46 
? DA anti-Lewis  DA untreated  (Lewis  X  DA)F1  +  663  1:16  7.83 --  0.08 
"  "  "  X  "  "  +  663  1:32  8.30 ±  0.05 
u  .  t~  X  ~  ~  q-  663  1:64  7.71  ±  0.12 
"  "  "  X  "  "  +  663  1:128  7.30 -4-  0.45 
"  "  "  X  "  "  -~  663  1:256  7.80 -4-  0.25 
? Lewis anti DA  Lewis untreated  (Lewis  X  DA)Ft  +  663  1:16  8.08  -4-  0.25 
"  "  "  X  "  "  +  663  1:32  7.66 ±  0.08 
~  .  u  X  ~  ~  +  663  1.64  7.75  ±  0.25 
"  "  "  X  "  "  q-  663  1:128  8.50 -4-  0.50 
* Cultivation was for 4 hr at 37°C in recognition DA ~  BN and BN ---r DA or for 7 hr at 37°C for all others, 
++ X  I0~ PMN cells/skin reaction, Average of 6-24 skin reactions. 
TABLE  V 
Lack  of Anti-RS(Lewis)  Activity  of Serum  675  Provoked  by Injection  of Normal  DA  Serum 
into  (Lewis X  DA)F1 Hosts 
Mixed spleen cell cultures* 
PAR~t  (-4-sE) 
Aggressors  Untreated targets 
DA  untreated  (Lewis  X  DA)F1  8,21  ~  0.18 
DA  q-  675  1:32  (Lewis  X  DA)FI  7,10  q-  0.57 
"  q-675  1:64  "  X  ....  6.94  ~  0.56 
"  q-675  1:128  "  X  ....  6.58  :tz  0.38 
"  +  675  1:256  "  X  "  "  7.31  ~  0.05 
"  +  675  1:512  "  X  ....  6.89  q-  0.07 
*  Cultivation  was  for 7  hr at  37°C. 
:~  X  10  6 PMN  cells/skin  reaction.  Average  of  12 skin reactions. HANSRUEDY  RAMSEIER  AND  JEAN  LINDENMANN  1089 
treatment of BN aggressor cells with serum 663 failed to inhibit their ability 
to recognize DA alloantigens. 
When  the  anti-alloantiserum  was  tested  for  either  DA  anti-Lewis  or  for 
Lewis anti-DA  activity by treating (Lewis X  DA)F1 target cells,  normal re- 
sponses were obtained. This indicated that serum 663  lacked both activities. 
To ascertain that a serum provoked similarly as serum 663 but by injections 
of normal DA rat serum failed to display anti-RS(Lewis) activity, the experi- 
ments  outlined in Table V  were done. The results  of this control serum 675 
show that it was totally inactive. 
DISCUSSION 
The  experiments reported demonstrate  that  the  activities  of  antisera  ob- 
tained after rejection of skin allografts, after injections of parental strain im- 
munocompetent cells into F1 hosts,  and  after injections of an  alloantiserum 
into similar hosts  can be determined by the  PAR  test.  Activities and  titers 
revealed themselves according to whether a serum directed itself to the recog- 
nizing (aggressor cells)  or to the recognized (target cells)  partner of mixed cell 
cultures. 
The unambiguous  demonstration of the activity of a  serum obtained after 
rejection of skin allografts is important. A posttransplantation serum appears 
to be directed exclusively against transplantation antigens. It failed to display 
activity against recognizing cells (Table I). From this and from other experi- 
ments with mouse and hamster alloantisera,  2 it may be concluded that  such 
sera  lack  anti-recognition  structure  (anti-RS)  activity.  In  contrast  to  this, 
antisera  provoked in  F1  hybrid animals  by  the  injection  of  parental  strain 
lymphoid cells manifest two activities (3). The high-titered activity is directed 
against recognition structures of donor-type cells for the antigen in  question; 
the low-titered serum component addresses itself to transplantation  antigens 
and thus appears to be an alloantiserum (Table II). The existence of this latter 
activity in an F1 serum must be traced to the antibody-forming capacity of 
the injected immunocompetent parental strain cells and to the fact that these 
cells encounter foreign transplantation  antigens  in  a  host  that  cannot reject 
them. While  this  is  a  plausible interpretation,  it is  surprising  that  the  allo- 
antibody activity produced by a small (10  6 cells) inoculum and its descendants 
is not completely removed by host tissue. The activity that  can be detected 
in the serum is perhaps low affinity antibody which escaped host absorption. 
That its activity could be demonstrated at all is witness to the sensitivity of 
the test system employed. 
2  Ramseier, H., and J. Lindenmann. Quantitative studies on antigenic recognition. IV. 
Specific inhibition of the recognition  process by alloantisera. Paper submitted for publication. 1090  ANTI-ALLOANTISERUM AND  RECEPTORS 
The  object  of  this  study  was  to  demonstrate  that  an  antiserum  directed 
against a particular set of recognition structures of lymphoid cells cannot only 
be produced  by injecting  cells bearing  such  structures,  but  also by injecting 
the  corresponding  alloantiserum  into  suitable  F1  hosts.  The latter  procedure 
seemed feasible since immunoglobulins  of alloantisera  are known  to combine 
with immunizing antigen. They might, therefore, have in their antigen-binding 
region the equivalent of what is considered to be the recognition site of immu- 
nocompetent cells.  The results summarized in Table IV constitute strong evi- 
dence for the view that this indeed is so. Alloantiserum DA anti-Lewis, which 
we viewed  as  representing  RS(Lewis),  elicited,  after injection into  (Lewis X 
DA)F~ hosts, an anti-alloantiserum which could be shown to act like an anti- 
RS(Lewis)  serum.  Thus  treatment  of  DA  spleen  cells,  expected  to  possess 
RS(Lewis),  with  this  anti-alloantiserum prevented recognition  of Lewis  anti- 
gens. The serum proved ineffective when employed in the treatment of Lewis 
spleen  cells  because  these  cells  lack  recognition  structures  directed  against 
their own antigens. The anti-alloantiserum was of high specificity. Treatment 
of DA lymphoid cells resulted in blockage of RS(Lewis)  only, whereas recog- 
nition  of  BN  alloantigens  remained  perfectly  normal.  Likewise,  BN  spleen 
cells treated with this anti-RS(Lewis)  serum were capable of recognizing DA 
alloantigens.  Clearly then,  specificity as revealed with  this  anti-alloantiserum 
was equal to that observed for anti-RS sera obtained by injections of immuno- 
competent cells (3, 4). In both cases serum-mediated inhibition was towards a 
particular set of RS only. Recognition structures not affected were free to inter- 
act with corresponding transplantation antigens. 
Our interpretation of the activity of this anti-alloantiserum received support 
by the observation that a  control serum,  elicited in  exactly the same way as 
the active serum except that normal DA rat serum rather than DA anti-Lewis 
serum  was  used  to  immunize  F1  hosts,  failed  to  show  any  anti-RS(Lewis) 
activity (Table V). 
It appears from these results that there might be no fundamental difference 
between antisera  to recognition  structures prepared either by injecting whole 
cells  bearing  antigenic  RS  or  by injecting  alloantibodies  carrying  a  specific 
antigen-binding  site  representing  immunogenic  RS.  However,  sera  obtained 
by these two immunization procedures have important secondary qualities by 
which they differ. As the data in Table IV illustrate, an anti-RS(Lewis) serum 
in  the form of an  anti-alloantiserum  failed  to display  activity when  used  to 
treat  (Lewis  X  DA)F1 target cells.  The serum showed neither anti-Lewis nor 
anti-DA activity. While  the latter activity was not expected to be present in 
this  serum, it was  considered  possible that  remnants  of the immunizing DA 
anti-Lewis serum, passaged through F1 hosts, might have been present in the 
F1  serum.  Despite the fact that each F1 host received a  total of 1 ml of this 
alloantiserum, no DA anti-Lewis activity could be found in the FI serum pool. ItANSRUEDY  RAMSEIER  AND  JEAN  LINDENMANN  1091 
This is sharply in contrast to the result obtained when RS-carrying cells were 
used as antigen (Table II). In this case a small but well-defined DA anti-Lewis 
titer  was present  in  the  F1  serum pool. This then might indicate  that  when 
alloantisera are used as antigen pure anti-RS  antisera are formed. The other 
quality by which F1 sera produced by cells and those provoked by alloantisera 
differ is the titer. For the two anti-RS sera presented this difference is fourfold. 
At first sight it seems surprising that an inoculum known to proliferate in FI 
hosts (10-14)  should yield a less active antiserum than a dead inoculum. Two 
observations might help to explain this.  First,  it has been observed that  the 
activity of an anti-RS  serum can be neutralized by a  corresponding alloanti- 
serum and, conversely, that the activity of an alloantiserum can be neutralized 
by a  fitting anti-RS serum3 Since in an F1 host that received parental strain 
lymphoid cells these two serum activities coexist, a neutralization process must 
continuously go on. This might result in a diminished anti-RS activity as well 
as in  a  diminished  alloantibody activity. The second point is interconnected 
to the first. Although the subject of current investigations, observations made 
so far have revealed that  the injection  of l0 G, 6  X  106, and even 200  X  106 
parental strain lymphoid cells into F~ hosts all resulted in similar anti-RS titers. 
Even though there is little doubt that donor cells will multiply in F1 animals 
in  response to foreign  transplantation  antigens  (10-14),  this process appears 
to plateau-off quite soon. It seems that irrespective of the dose of donor cells 
used, mutual neutralization  takes place, the only difference being the level at 
which this process works. The employment of alloantiserum instead of lymphoid 
cells appears to circumvent this neutralization. While the injected serum might 
serve as the neutralizer of the product it calls forth, only quantitative aspects 
seem to influence the outcome. The observation that with the presently used 
immunization regime FI sera lacked alloantibody activity would indicate that 
the  serum  might  have  been  used  up  during  immunization.  Consequently, 
none or very little could act as an in vivo neutralizer of the anti-alloantiserum 
activity. 
The  significance  of  this  study lies  in  the  demonstration  that  the  antigen- 
combining site of alloantibodies  can be used as antigen in the preparation of 
antisera  to  cellular  recognition  structures.  This  observation  strongly  favors 
the view that antigen-combining sites of alloantibodies and cellular receptors 
for  transplantation  antigens  might  be  very  similar  entities.  The  antigen- 
combining  sites  of  alloantibodies  are  known  to  be  located  in  the  variable 
region of immunoglobulin molecules. Since antibody can be raised against this 
region and since the activity of this antibody and that prepared against cellular 
recognition  structures  is  not  distinguishable,  both  being  directed  against 
3 Ramseier, H., and J. Lindenmann. Similarity of cellular recognition structures for histo- 
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specific recognition structures, we conclude that the important part of cellular 
receptors for transplantation antigens might also consist of the variable region 
of an immunoglobulin. 
This conclusion is strongly supported by another set of experiments  3 to be 
mentioned briefly. In these, it was shown that the activity of a mouse anti-RS 
serum provoked by the  injection of immunocompetent parental  strain  cells 
into F1 hosts could be neutralized by a mouse alloantiserum representing the 
corresponding RS. Thus a  serum,  (A X  CBA)FI anti-A RS(CBA) capable of 
preventing recognition of CBA alloantigens by A  aggressor cells,  completely 
lost its inhibitory activity upon simple incubation with alloantiserum A anti- 
CBA,  representing  RS(CBA).  Coincubation  of  this  anti-RS(CBA)  serum 
with  a  nonmatching  alloantiserum  CBA  anti-C57BL/6, representing  RS- 
(C57BL/6),  failed to neutralize. Conversely, the  activity of mouse alloanti- 
serum A anti-CBA, representing RS(CBA), could be neutralized by the fitting 
anti-RS serum (A X  CBA)F1 anti-A RS(CBA) but not by the nonfitting (A X 
C57BL/6)FI anti-A RS(C57BL/6)  antiserum. 
These experiments and those reported in the present communication strongly 
favor an antigenic similarity between the antigen-binding region of immuno- 
globulin molecules and  of cellular recognition structures.  Antigenic determi- 
nants located on the variable region of immunoglobulin molecules are called 
idiotypes (15  17).  For reasons given elsewhere  3 we suggest that the antigenic 
determinants  characterizing  alloantibodies  be  called  "aliotypes". Using  this 
terminology, we can state that recognition structures  on lymphoid cells  and 
the corresponding alloantibodies are of the same aliotype. 
The  core  of  data presented  means nothing  else  than  direct  experimental 
evidence for what has been expressed before by many researchers (18-26). To 
quote  Mitchison  (27)  it  has  to  be  assumed  "that nothing except  antibody 
recognizes antigen, and we must therefore assume that the receptor for antigen 
is  antibody already present at a  site, in or  on the cell,  prior  to exposure to 
antigen." The results of this report add weight to the likelihood of this inter- 
pretation. 
SUMMARY 
The  possibility that  a  rat  alloantiserum DA  anti-Lewis possesses  similar 
recognition structures for Lewis transplantation antigens, as do DA immuno- 
competent cells,  was investigated by raising an  antiserum against this  allo- 
antiserum in (Lewis X  DA)F1 hosts. This antiserum, as well as one provoked 
by injecting DA lymphoid cells, was active against recognition structures for 
Lewis  antigens  of  DA  immunocompetent  cells.  The  anti-(DA  anti-Lewis) 
antiserum displayed the  same  degree  of specificity as  was  found previously 
for anti-recognition structure sera prepared by injecting parental strain lymph- 
oid cells into F1 hosts. Since the activities of antisera raised against cell-bound ItANSRUEDY RAMSEIER AND JEAN  LINDENA~ANN  1093 
receptors  or  against  the  antigen-binding  region  of  an  immunoglobulin  were 
indistinguishable,  it was  concluded that the functional part  of cell-associated 
receptors might be structurally similar to the variable portion of an immuno- 
globulin. 
We wish to thank Mrs. M. Heizmann, Miss R. Keller, and Miss R. Leemann for expert 
technical assistance. 
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